Main logo
tutorial arrow
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.

Design Peptides Against Bacterial Biofilms dPABBs


A web server that facilitates the prediction and design of anti-biofilm peptides, that offer a promising avenue for the development of new standalone therapeutics or adjuvants acting synergistically with pre-existing antibiotics. dPABBs attempts to develop a prediction strategy for the identification and optimisation of such anti-biofilm peptides, offering a comprehensive platform that allows the user to check both peptides and protein fragments for potential anti-biofilm activity and provides features like simultaneous multi-model predictions and mutant generation.

User report

tutorial arrow
Vote up tools and offer feedback
Give value to tools and make your expertise visible
Give your feedback on this tool
Sign up for free to join and share with the community

0 user reviews

0 user reviews

No review has been posted.

dPABBs forum

tutorial arrow
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.
Take part in the discussion
Sign up for free to ask question and share your advices

No open topic.

dPABBs classification

dPABBs specifications

Web user interface
Input data:
Peptide or protein sequence(s)
Computer skills:
Restrictions to use:
Input format:
Single letter code or FASTA

dPABBs support


  • Anshu Bhardwaj <>


tutorial arrow
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.
Promote your work
Sign up for free to badge your contributorship



Open Source Drug Discovery Unit, Council of Scientific and Industrial Research, New Delhi, India; Academy of Scientific and Innovative Research, New Delhi, India; Bhaskaracharya College of Applied Sciences, University of Delhi, New Delhi, India

Funding source(s)

This work was partly supported by the CSIR and by the UGC.

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.